Propanc Biopharma Inc (PPCB)

[kneester]

I am a new poster in this forum, and one who is far from having any of the technical expertise of 90% of you all with day trading. Having been a follower of this board for 2 months, I too was excited about the potential of the focus of this company's research to help with new and potentially life-changing cancer treatment protocols.
Also, I... like most, need some $ profit $ for my remaining life's account.

However when some questioned the recent track records of some of the managing officers of this company, several doubts arose. One being:
http://www.dailyecho.co.uk/news/11685943.Hampshire_doctor_keeps_job_after_experimental_treatment_tribunal/Dr "Julian Kenyon can keep his job but must work under conditions after a tribunal......"
Also the major hype (which I bought into and lost big-time) of the New York Times article..... "Propanc Health Group Corporation(PINKSHEETS:PPCH) ("Propanc" or "the Company"), an emerging healthcare company focusing on the development of new and proprietary treatments for cancer patients, today announced the Company will be featured in the NY Times Sunday Magazine, under Health Essentials: Cancer Prevention & Treatment, April 19th.
As nicely as it was presented in 5 slick pages (but not in my Harrisburg, Pa edition), it turned out to be extremely misleading. This "Feature" had nothing at all to do with the seemingly "implied endorsement" of the New York Times staff, but rather like a company similar to Renewal By Andersen paying to place an insert for particular regions of the country where the demographics matched the desired money caches.
I truly hope PPCH is for real, but it seems like they are long way off from putting anything FDA approved of substance into the marketplace, while novice investors are drained of their resources. No sour grapes, as rewards take risk, and risk takes balls. Just curious on someone's true analysis of this cast of characters running this company.